Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting
Provided By GlobeNewswire
Last update: Apr 28, 2025
- Oral presentation on tau silencing gene therapy VY1706, which has previously shown up to 73% knockdown of tau mRNA in NHPs in the CNS following a single IV dose of 1.3e13 vg/kg -
Read more at globenewswire.com
